Análisis de la cuota de mercado y oportunidades de terapias con ARN de interferencia pequeño (ARNip) 2025-2031
Small Interfering RNA (siRNA) Therapeutics Market Report Analysis
Small Interfering RNA (siRNA) Therapeutics Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- Horizon Discovery
- GlaxoSmithKline
- Sirna Therapeutics, Inc.
- Alnylam Pharmaceuticals
- Sanofi Genzyme
- Olix Pharmaceuticals
- Silence Therapeutics AG
- Calando Pharmaceuticals
- Arbutus Biopharma Corp
Regional Overview
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
- Medio Oriente y África
Market Segmentation
By Indicación
- Oncología
- Enfermedades Cardiovasculares
- Trastornos Respiratorios
- Trastornos Neurodegenerativos
- Enfermedades Infecciosas
- Otros
By Tipos
- terapia sistémica basada en liposomas
- terapia sistémica basada en nanopartículas
- otros
By Usuario Final
- Laboratorio de Diagnóstico
- Laboratorios de Investigación y Académicos
By Geografía
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
Get Free Sample For